Abstract
Generics Producers in Asia: Where Are the Big Opportunities provides newly
researched company profiles and competitive intelligence on 50 leading
generics producers (see full list below) operating in 14 key markets:
Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Pakistan,
Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.
Generics Producers in Asia: Where Are the Big Opportunities also evaluates key
industry trends and growth dynamics, and features BMI' s independent 5-year
industry forecasts for each market to end-2012. Each of the 14 generics
markets is also ranked according to the competitiveness of the regulatory and
business operating environment, and growth potential of the generics segment
over the 5-year forecast horizon.
BMI Asia Generics View
BMI values the Asian generic drug sector at US$41.8bn, and we forecast 12.7%
year-on-year growth through 2012. Generics Producers in Asia: Where Are the
Big Opportunities examines the key drivers of this rapid growth (growing
economies, cost-containment policies, ageing populations and the emergence of
chronic diseases), and the opportunities arising for multinational and local
generics producers alike.
| 
View Cart
